Hepatitis B immunization strategies: timing is everything

Mackie, Christopher O.; Buxton, Jane A.; Tadwalkar, Sayali; Patrick, David M.
January 2009
CMAJ: Canadian Medical Association Journal;1/20/2009, Vol. 180 Issue 2, p196
Academic Journal
The article focuses on the long term effectiveness and scheduling of Hepatitis B Virus (HBV) immunization programs for infants and adolescents. It notes the most appropriate timing of vaccination for the immunization against HBV as discussed by the Vaccine advisory bodies. It suggests that HBV immunization vaccines should be given to infants to reduce risk of cirrhosis and hepatocellular carcinoma which occur up to 90% of infants and 1% to 5% of adults. Among the 193 member countries of the World Health Organization (WHO), 171 had implemented the vaccination of hepatitis B to infants as recommended by the Expanded Programme on Immunization in 2007.


Related Articles

  • Prevention of hepatitis B virus infection: from the past to the future. Orlando, R.; Foggia, M.; Maraolo, A.; Mascolo, S.; Palmiero, G.; Tambaro, O.; Tosone, G. // European Journal of Clinical Microbiology & Infectious Diseases;Jun2015, Vol. 34 Issue 6, p1059 

    About 3-5 % of the world's population is chronically infected by hepatitis B virus (HBV) and is at risk of developing liver cirrhosis or hepatocellular carcinoma. The risk of dying prematurely because of chronic HBV infection is higher in younger people. The current strategies to prevent HBV...

  • Stop Making Excuses: Understanding Hepatitis B and the Global Failure to Act. Janik-Marusov, Laura L. // Global Health Governance;Apr2011, Vol. 4 Issue 2, p1 

    Hepatitis B virus (HBV) is one hundred times more contagious than HIV/AIDS and is one of the leading causes of primary liver cancer. Merck created the first hepatitis B vaccine in 1982, but the distribution of it remains a global problem as does sustained HBV research, monitoring, and...

  • Global progress towards universal childhood hepatitis B vaccination, 2003.  // Weekly Epidemiological Record;10/17/2003, Vol. 78 Issue 42, p366 

    Reports on the World Health Organization’s (WHO) goal to integrate hepatitis B vaccination drive into their routine child immunization programmes in all countries by 1997. Introduction of universal infant or childhood hepatitis B vaccination programs by 151 WHO member states; Acceleration...

  • Hepatocellular carcinoma in urban born blacks: frequency and relation to hepatitis B virus infection. Kew, M.C.; Kassianides, C.; Hodkinson, J.; Coppin, A.; Paterson, A.C. // British Medical Journal (Clinical Research Edition);11/22/1986, Vol. 293 Issue 6558, p1339 

    Examines hepatocellular carcinoma in urban born southern African blacks. Frequency of hepatocellular carcinoma; Prevalence of hepatitis B markers; Administration of Hepatitis B virus vaccines.

  • Hepatitis B Immunization in Health Care Workers: Needs and Opportunities. Torre, Giuseppe La; Saulle, Rosella; Unim, Brigid // Hepatitis Monthly;2011, Vol. 11 Issue 8, p664 

    The article discusses a study conducted by SM Alavian et al. which was aimed at identifying anti-Hepatitis B antibody titer in dental health providers in Iran and examining the likely correlation between the level of immunity and a number of important factors. Hepatitis B virus (HPV) is...

  • KAP Study about Hepatitis B among Medical and Paramedical Staff in Tikrit City. Noaman, Areej Muthana; Ahmed, Athraa Essa; Alanee, Sadoon A. // Tikrit Medical Journal;2012, Vol. 18 Issue 2, p261 

    Hepatitis B is a global infectious disease with estimated two billions of the world population have contracted the infection, of them there are 350 thousand with chronic infection. Hepatitis B disease may lead to state of chronic carrier, liver cirrhosis and failure or hepatocellular carcinoma....

  • 20-Years of Population-Based Cancer Registration in Hepatitis B and Liver Cancer Prevention in The Gambia, West Africa. Bah, Ebrima; Carrieri, Maria Patrizia; Hainaut, Pierre; Bah, Yusupha; Nyan, Ousman; Taal, Makie // PLoS ONE;Sep2013, Vol. 8 Issue 9, p1 

    Background:The Gambia Hepatitis Intervention Study (GHIS) was designed as a randomised control trial of infant hepatitis B vaccination applied to public health policy, with the main goal of preventing primary liver cancer later in adult life in The Gambia. To that effect, the National Cancer...

  • Worldwide implementation of hepatitis B vaccination of newborns, 2006.  // Weekly Epidemiological Record;11/28/2008, Vol. 83 Issue 48, p429 

    The article reports on the findings of the survey from the 2006 World Health Organization (WHO) and United Nations International Children's Emergency Fund (UNICEF) concerning the implementation of hepatitis B vaccination of newborns. WHO and UNICEF have published coverage estimates for routine...

  • Trends of Acute Hepatitis B Notification Rates in Eastern China from 2005 to 2013. Wang, Zhifang; Chen, Yaping; Pan, Jinren // PLoS ONE;Dec2014, Vol. 9 Issue 12, p1 

    Zhejiang Province was a high endemicity for hepatitis B disease in the 1990's. A number of measures implemented since then have begun to control and prevent hepatitis B. In 1992, hepatitis B vaccine came on the market. In 2002, hepatitis B vaccine was included in the national Expanded Programme...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics